HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Equity Capital Markets

<ul>
<li>Although adopting a multi-brand strategy, <a href="https://www.smartkarma.com/entities/shanghai-chicmax-cosmetic-co-ltd" target="_blank" data-smartkarma-citation="entities:35503:1" rel="noopener">Shanghai Chicmax Cosmetic (CMC HK)</a>’s revenue mainly came from three brands, namely KANS, One Leaf and Baby Elephant, with no blockbuster brands afterwards. </li>
<li>Chicmax emphasizes marketing/promotion over R&amp;D, which has dragged down net profit margin despite solid revenues and gross profit margins. Product quality problem is also a concern.</li>
<li>We hope that Chicmax can increase R&amp;D investment and strengthen product innovation and quality control, so as to gain more consumer loyalty and trust, especially in high-end market. </li>
</ul>


Although adopting a multi-brand strategy, Shanghai Chicmax Cosmetic (CMC HK)’s revenue mainly came from three brands, namely KANS, One Leaf and Baby Elephant, with no blockbuster brands afterwards. 
Chicmax emphasizes marketing/promotion over R&amp;D, which has dragged down net profit margin despite solid revenues and gross profit margins. Product quality problem is also a concern.
We hope that Chicmax can increase R&amp;D investment and strengthen product innovation and quality control, so as to gain more consumer loyalty and trust, especially in high-end market. 


Pre-IPO Shanghai Chicmax Cosmetic - The Current Development Strategy Will Not Go Far

IPOs and Catalysts/Events, Global Equity Research Ltd

Arun George

IPOs and Catalysts/Events

Uncompromised, Independent, Conflict-Free Research

Global Equity Research Ltd

Global Equity Research was started in 2017 by a group of experienced research professionals. It was founded on a passionate belief in the importance and the need for uncompromised, independent, conflict-free research. We aim to provide differentiated and actionable primary and bottom up fundamental research.

<div><p><a href="https://www.smartkarma.com/entities/fsn-e-commerce-ventures-nykaa" target="_blank" data-smartkarma-citation="entities:33796:1" rel="noopener">FSN E-Commerce Ventures (Nykaa) (1003622D IN)</a> provides e-retailing of beauty and fashion products through two verticals Nykaa (beauty and personal care) and Nykaa Fashion (apparel and accessories). Nykaa is the largest speciality beauty and personal care platform in India as measured by the value of products sold in the FY21 and in 5MFY22 (five months ending August), according to RedSeer.   </p></div><div>
<p>Nykaa will launch its IPO on 28 October. The IPO comprises a primary raise of Rs6,300 million ($84 million) with the remainder 42.0 million secondary shares. At the indicative price range of Rs1,085-1,125 per share, the gross proceeds are Rs51.8-53.2 billion ($691-714 million). An anchor placement of up to Rs23.4 billion ($312 million) will open on 27 October, and the IPO will close on 1 November. </p>
<p>In <a href="https://www.smartkarma.com/insights/nykaa-ipo-initiation-beauty-parade" target="_blank" data-smartkarma-citation="insights:58791" rel="noopener">Nykaa IPO Initiation: Beauty Parade</a>, we stated that Nykaa has a strong positioning in India’s e-commerce beauty products industry, underpinned by the strong brand recognition of the ‘Nykaa’ brand. The financial performance is solid with strong growth, rising margins and cash generation. These characteristics should enable Nykaa to hold its own against intensifying competition. We concluded that Nykaa has attractive fundamentals.</p>
</div><div><div class="content-highlight"><p>In <a href="https://www.smartkarma.com/insights/nykaa-ipo-on-trend" target="_blank" data-smartkarma-citation="insights:59407" rel="noopener">Nykaa IPO: On Trend</a>, we stated that the recent results from the updated prospectus reinforce our view that Nykaa has the ability to deliver strong profitable growth. Our valuation analysis suggests that the IPO price range is attractive.</p></div></div>

FSN E-Commerce Ventures (Nykaa) (1003622D IN) provides e-retailing of beauty and fashion products through two verticals Nykaa (beauty and personal care) and Nykaa Fashion (apparel and accessories). Nykaa is the largest speciality beauty and personal care platform in India as measured by the value of products sold in the FY21 and in 5MFY22 (five months ending August), according to RedSeer.   
Nykaa will launch its IPO on 28 October. The IPO comprises a primary raise of Rs6,300 million ($84 million) with the remainder 42.0 million secondary shares. At the indicative price range of Rs1,085-1,125 per share, the gross proceeds are Rs51.8-53.2 billion ($691-714 million). An anchor placement of up to Rs23.4 billion ($312 million) will open on 27 October, and the IPO will close on 1 November. 
In Nykaa IPO Initiation: Beauty Parade, we stated that Nykaa has a strong positioning in India’s e-commerce beauty products industry, underpinned by the strong brand recognition of the ‘Nykaa’ brand. The financial performance is solid with strong growth, rising margins and cash generation. These characteristics should enable Nykaa to hold its own against intensifying competition. We concluded that Nykaa has attractive fundamentals.
In Nykaa IPO: On Trend, we stated that the recent results from the updated prospectus reinforce our view that Nykaa has the ability to deliver strong profitable growth. Our valuation analysis suggests that the IPO price range is attractive.

<p><a href="https://www.smartkarma.com/entities/fsn-e-commerce-ventures-nykaa" target="_blank" data-smartkarma-citation="entities:33796:1" rel="noopener">FSN E-Commerce Ventures (Nykaa) (1003622D IN)</a> provides e-retailing of beauty and fashion products through two verticals Nykaa (beauty and personal care) and Nykaa Fashion (apparel and accessories). Nykaa is the largest speciality beauty and personal care platform in India as measured by the value of products sold in the FY21 and in 5MFY22 (five months ending August), according to RedSeer. </p><p>Nykaa will launch its IPO on 28 October. The IPO comprises a primary raise of Rs6,300 million ($84 million) with the remainder 42.0 million secondary shares. At the indicative price range of Rs1,085-1,125 per share, the gross proceeds are Rs51.8-53.2 billion ($691-714 million). The secondary sellers include promoters Falguni Nayar and Sanjay Nayar (through Sanjay Nayar Family Trust), TPG and Lighthouse.</p><p>In <a href="https://www.smartkarma.com/insights/nykaa-ipo-initiation-beauty-parade" target="_blank" data-smartkarma-citation="insights:58791" rel="noopener">Nykaa IPO Initiation: Beauty Parade</a>, we stated that Nykaa has a strong positioning in India’s e-commerce beauty products industry, underpinned by the strong brand recognition of the ‘Nykaa’ brand. It has been able to retain a large customer base, leading to repeat orders such that existing consumers accounted for 70% of GMV in FY21. Nykaa also has relationships with 2,476 brands but with no dependence on any brand or product. The financial performance is solid with strong growth, rising margins and cash generation. These characteristics should enable Nykaa to hold its own against intensifying competition. We concluded that Nykaa has attractive fundamentals.</p><div class="content-highlight"><p>In this note, we look at the updated prospectus which outlines the 1QFY22 results (for the quarter ending June) and KPIs for 5MFY22 (five months ending August). Overall, the recent results reinforce our view that Nykaa has the ability to deliver strong profitable growth. We will discuss valuation in our next note.  </p></div>

FSN E-Commerce Ventures (Nykaa) (1003622D IN) provides e-retailing of beauty and fashion products through two verticals Nykaa (beauty and personal care) and Nykaa Fashion (apparel and accessories). Nykaa is the largest speciality beauty and personal care platform in India as measured by the value of products sold in the FY21 and in 5MFY22 (five months ending August), according to RedSeer. Nykaa will launch its IPO on 28 October. The IPO comprises a primary raise of Rs6,300 million ($84 million) with the remainder 42.0 million secondary shares. At the indicative price range of Rs1,085-1,125 per share, the gross proceeds are Rs51.8-53.2 billion ($691-714 million). The secondary sellers include promoters Falguni Nayar and Sanjay Nayar (through Sanjay Nayar Family Trust), TPG and Lighthouse.In Nykaa IPO Initiation: Beauty Parade, we stated that Nykaa has a strong positioning in India’s e-commerce beauty products industry, underpinned by the strong brand recognition of the ‘Nykaa’ brand. It has been able to retain a large customer base, leading to repeat orders such that existing consumers accounted for 70% of GMV in FY21. Nykaa also has relationships with 2,476 brands but with no dependence on any brand or product. The financial performance is solid with strong growth, rising margins and cash generation. These characteristics should enable Nykaa to hold its own against intensifying competition. We concluded that Nykaa has attractive fundamentals.In this note, we look at the updated prospectus which outlines the 1QFY22 results (for the quarter ending June) and KPIs for 5MFY22 (five months ending August). Overall, the recent results reinforce our view that Nykaa has the ability to deliver strong profitable growth. We will discuss valuation in our next note.  

Equity Bottom-Up

Yunnan Botanee Bio-Technology / Equity Bottom-Up

Yunnan Botanee Bio-Technology (300957 CH)

<p>On August 10, <a href="https://www.smartkarma.com/entities/yunnan-botanee-bio-technology" target="_blank" data-smartkarma-citation="entities:33954:1" rel="noopener">Yunnan Botanee Bio-Technology (300957 CH)</a> released its 2021/1H financial results. In the first half of 2021, Botanee achieved revenue of RMB1.412 billion, up 49.94% YoY. Net profit attributed to shareholders was RMB265 million, up 65.28% YoY. Net profit after deducting non-recurring gains and losses was RMB253 million, up 68.46% YoY. The performance was outstanding, but the market seemed to have very modest response. Botanee’s share price was just up 1.02% on August 11 and 3.98% on August 12 but down 5.35% on August 13. So, how is this Company? What are the concerns behind positive financial results?</p>

On August 10, Yunnan Botanee Bio-Technology (300957 CH) released its 2021/1H financial results. In the first half of 2021, Botanee achieved revenue of RMB1.412 billion, up 49.94% YoY. Net profit attributed to shareholders was RMB265 million, up 65.28% YoY. Net profit after deducting non-recurring gains and losses was RMB253 million, up 68.46% YoY. The performance was outstanding, but the market seemed to have very modest response. Botanee’s share price was just up 1.02% on August 11 and 3.98% on August 12 but down 5.35% on August 13. So, how is this Company? What are the concerns behind positive financial results?

Botanee Bio-Technology (300957.CH)-The Success of WINONA Cannot Cover up the Concerns on the Outlook

EBeauty Holdings / Equity Capital Markets

<p><a href="https://www.smartkarma.com/entities/ebeauty-holdings" target="_blank" data-smartkarma-citation="entities:33505:1" rel="noopener">EBeauty Holdings (1894926D HK)</a> is the largest beauty brand e-commerce enablement service provider by GMV (gross merchandise value) facilitated or generated in China, with a market share of 13.3% in 2020, according to iResearch. eBeauty primarily executes the branding and marketing strategies that the brand partners have designed, operating their official online stores, while in some cases it provides marketing strategy advisory to brand partners to help them formulate their marketing strategies.</p><p>eBeauty is pre-marketing an HKEx IPO to raise around $600 million, according to press reports. The shareholders include Genesis Capital, <a href="https://www.smartkarma.com/entities/ping-an-insurance-grp-co-of-china-ltd" target="_blank" data-smartkarma-citation="entities:12880:1" rel="noopener">Ping An Insurance (H) (2318 HK)</a>, <a href="https://www.smartkarma.com/entities/bilibili-inc" target="_blank" data-smartkarma-citation="entities:26793:1" rel="noopener">Bilibili Inc (BILI US)</a> and Mass Ave Global.</p><p>eBeauty is a play on the rising complexity of China’s beauty e-commerce industry which has resulted in more brands out-sourcing their e-commerce operations to specialized brand e-commerce enablement service providers (such as eBeauty). The beauty e-commerce industry is fast-evolving, with mounting demands for personalised marketing strategy, multi-channel operation capabilities and technology solutions. These demanding requirements force a significant proportion of beauty brands to engage service providers who offer a suite of services in the e-commerce value chain.</p><div class="content-highlight"><p>eBeauty is capitalising on these industry dynamics by delivering solid organic growth, rising margins and good cash generation. Overall, we believe that eBeauty is worth a closer look.</p></div>

EBeauty Holdings (1894926D HK) is the largest beauty brand e-commerce enablement service provider by GMV (gross merchandise value) facilitated or generated in China, with a market share of 13.3% in 2020, according to iResearch. eBeauty primarily executes the branding and marketing strategies that the brand partners have designed, operating their official online stores, while in some cases it provides marketing strategy advisory to brand partners to help them formulate their marketing strategies.eBeauty is pre-marketing an HKEx IPO to raise around $600 million, according to press reports. The shareholders include Genesis Capital, Ping An Insurance (H) (2318 HK), Bilibili Inc (BILI US) and Mass Ave Global.eBeauty is a play on the rising complexity of China’s beauty e-commerce industry which has resulted in more brands out-sourcing their e-commerce operations to specialized brand e-commerce enablement service providers (such as eBeauty). The beauty e-commerce industry is fast-evolving, with mounting demands for personalised marketing strategy, multi-channel operation capabilities and technology solutions. These demanding requirements force a significant proportion of beauty brands to engage service providers who offer a suite of services in the e-commerce value chain.eBeauty is capitalising on these industry dynamics by delivering solid organic growth, rising margins and good cash generation. Overall, we believe that eBeauty is worth a closer look.

EBeauty Holdings IPO Initiation: Attention Pays

China

Guangdong Marubi Biotechnology Co., Ltd. manufactures cosmetics products. The Company produces water creams, clean creams, masks, eye creams, and other products. Guangdong Marubi Biotechnology markets its products throughout China.

Guangdong Marubi Biotechnology (603983 CH)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Guangdong Marubi Biotechnology (603983 CH)

Pre-IPO Shanghai Chicmax Cosmetic - The Current Development Strategy Will Not Go Far

Emphasizing marketing over R&D drives the current growth, but it's not enough for Chicmax to go further. Low net profit/quality issue/weak product...

Xinyao (Criss) Wang

Nykaa IPO: Valuation Insights

Nykaa will launch its IPO on 28 October to raise gross proceeds of $691-714 million. Our valuation analysis suggests that the IPO price range is...

Arun George

Nykaa IPO: On Trend

In this note, we look at the updated prospectus which outlines 1QFY22 results and KPIs for 5MFY22. The recent results reinforce our view that Nykaa...

Arun George

Botanee Bio-Technology (300957.CH)-The Success of WINONA Cannot Cover up the Concerns on the Outlook

The article analyzed a popular skin care product company Botanee in terms of the market potential, 2021H1 performance, strength, comparison with...

Xinyao (Criss) Wang

EBeauty Holdings IPO Initiation: Attention Pays

eBeauty is pre-marketing an HKEx IPO to raise around $600 m. eBeauty is capitalising on favourable industry dynamics by delivering solid organic...

Arun George

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)